Literature DB >> 21655156

Digital necrosis induced by erlotinib treatment in metastatic adenocarcinoma of the lung.

Pierluigi Ballardini1, Guido Margutti, Roberto Manfredini.   

Abstract

Entities:  

Keywords:  Digital necrosis; erlotinib; lung cancer; systemic sclerosis

Year:  2011        PMID： 21655156      PMCID： PMC3108863          DOI： 10.3747/co.v18i3.782

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  3 in total

1.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

2.  Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.

Authors:  Megan E B Clowse; Fredrick M Wigley
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

3.  Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?

Authors:  Christian Beyer; Jörg H W Distler; Oliver Distler
Journal:  Swiss Med Wkly       Date:  2010-09-01       Impact factor: 2.193
  3 in total
  1 in total

Review 1.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.